Nonobvious obstructive meibomian gland dysfunction

Cornea

Volumn 29, Issue 12, 2010, Pages 1333-1345

  Blackie, Caroline A ^a,b   Korb, Donald R ^a,b   Knop, Eric ^c   Bedi, Raman ^b,d   Knop, Nadja ^c   Holland, Edward J ^e  

^a Korb Associates   (United States)

^b TearScience Inc   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e Cincinnati Eye Institute   (United States)

Author keywords

evaporative dry eye; meibomian gland functionality; MGD; nonobvious obstructive meibomian gland dysfunction

Indexed keywords

ANDROGEN; AZITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; DOXYCYCLINE; LIPID; MINOCYCLINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TETRACYCLINE; WATER OIL CREAM;

BLEPHARITIS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; EYE INFLAMMATION; EYELID DISEASE; FUNCTIONAL ANATOMY; HEAT TRANSFER; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; KERATINIZATION; MASSAGE; MEIBOMIAN GLAND; NOMENCLATURE; NONOBVIOUS OBSTRUCTIVE MEIBOMIAN GLAND DYSFUNCTION; PRESSURE; PRIORITY JOURNAL; REVIEW; SEBACEOUS GLAND DISEASE; STANDARDIZATION;

DRY EYE SYNDROMES; EYELID DISEASES; HUMANS; LIPID METABOLISM; MEIBOMIAN GLANDS; TEARS;

EID: 78650515801     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181d4f366     Document Type: Review

References (145)

1. Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye. 1991;5(pt 4):395-411.
2. Tiffany JM. Physiological functions of the meibomian glands. Prog Retin Eye Res. 1995;14:47-74.
3. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol. 1996;40:343-367.
4. Foulks GN, Bron AJ. Meibomian gland dysfunction: A clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003;1: 107-126.
5. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf. 2004;2:149-165.
6. Lemp MA, Baudouin C, Baun J. The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf. 2007;5:75-92. (Pubitemid 351902651)
7. KrollMW, Efimov IR, Tchou PJ. Present understanding of shock polarity for internal defibrillation: The obvious and non-obvious clinical implications. Pacing Clin Electrophysiol. 2006;29:885-891.
8. Leizerovich GS, Taranukha NA. Nonobvious features of dynamics of circular cylindrical shells. Mech Solids. 2008;43:246-253.
9. Cherkasov A, Jones SJM. An approach to large scale identification of non-obvious structural similarities between proteins. BMC Bioinformatics. 2004;5:1-11.
10. Pennazio M, Arrigoni A, Rocci MP, et al. Does jejunoscopy improve the diagnostic yield in patients with diarrhea and or malabsorption of nonobvious origin. Gastroenterology. 1995;108(Suppl):A313.
11. Victory P, Alvarezlarena A, Germain G, et al. A non-obvious reaction pathway in the formation of 2-aminobenzene-1,3-dicarbonitriles from alpha, beta-unsaturated ketones or aldehydes. Tetrahedron. 1995;51: 253-242.
12. Goto E, Monden Y, Takano Y, et al. Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol. 2002;86:1403-1407.
13. Bron AJ, Tiffany JM, Gouveia SM, et al. Functional aspects of the tear film lipid layer. Exp Eye Res. 2004;78:347-360.
14. Lemp MA, Nichols KK. Blepharitis in the United States 2009: A survey based perspective on prevalence and treatment. Ocul Surf. 2009; 7(Suppl):S1-S22.
15. TFOS Newsletter. September 2008.
16. Wolff E. The muco-cutaneous junction of the lid-margin and the distribution of the tear fluid. Trans Ophthalmol Soc U K. 1946;66:291-308.
17. Weingeist TA. Fine structure and function of ocular tissues. The glands of the ocular adnexa. Int Ophthalmol Clin. 1973;13:243-261.
18. Jester JV, Nicolaides N, Kiss-Palvolgyi I, et al. Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD. Invest Ophthalmol Vis Sci. 1989;30:936-945. (Pubitemid 19140187)
19. Tiffany JM. Individual variations in human meibomian lipid composition. Exp Eye Res. 1978;27:289-300.
20. Tiffany JM. The role of meibomian secretion in the tears. Trans Ophthalmol Soc U K. 1985;104(pt 4):396-401.
21. Tiffany JM. The lipid secretion of the meibomian glands. Adv Lipid Res. 1987;22:1-62.
22. Nicolaides N, Kaitaranta JK, Rawdah TN, et al. Meibomian gland studies: Comparison of steer and human lipids. Invest Ophthalmol Vis Sci. 1981;20:522-536.
23. Nicolaides N. Recent findings on the chemical composition of the lipids of steer and human meibomian glands. In: Holly EJ, ed. The Preocular Tear Film In Health, Disease and Contact Lens Wear. Lubbock, TX: Dry Eye Institute; 1986:570-596.
24. Nicolaides N, Santos EC, Smith RE, et al. Meibomian gland dysfunction. III. Meibomian gland lipids. Invest Ophthalmol Vis Sci. 1989;30:946-951.
25. Shine WE, McCulley JR. Polar lipids in human meibomian gland secretions Curr Eye Res. 2003;26:89-94.
26. Shine WE, McCulley JR. Meibomianitis: Polar lipid abnormalities. Cornea. 2004;23:781-783.
27. Nichols KK, Ham BM, Nichols JJ. Identification of fatty acids and fatty acid amides in human meibomian gland secretions. Invest Ophthalmol Vis Sci. 2007;48:34-39.
28. Butovich IA, Millar TJ, Ham BM. Understanding and analyzing meibomian lipids-a review. Curr Eye Res. 2008;33:405-420.
29. Tiffany JM, Marsden RG. The influence of composition on physical properties of meibomian secretion. In: Holly EJ, ed. The Preocular Tear film In Health, Disease and Contact Lens Wear. Lubbock, TX: Dry Eye Institute; 1986:597-608.
30. Ong BL, Larke JR. Meibomian gland dysfunction: Some clinical, biochemical and physical observations. Ophthalmic Physiol Opt. 1990; 10:144-148.
31. Sullivan DA, Rocha EM, Ullman MD, et al. Androgen regulation of the meibomian gland. Adv Exp Med Biol. 1998;438:327-331.
32. Sullivan DA, Yamagami H, Liu M, et al. Sex steroids, the meibomian gland and evaporative dry eye. Adv Exp Med Biol. 2002;506(pt A): 389-399.
33. Yamada M, Mochizuki H, Kawai M, et al. Decreased tear lipocalin concentration in patients with meibomian gland dysfunction. Br J Ophthalmol. 2005;89:803-805.
34. Millar TJ, Mudgil P, Butovich IA, et al. Adsorption of human tear lipocalin to human meibomian lipid films. Invest Ophthalmol Vis Sci. 2009;50:140-151.
35. Mishima S, Maurice DM. The oily layer of the tear film and evaporation from the corneal surface. Exp Eye Res. 1961;1:39-45.
36. Holly FJ. Physical chemistry of the normal and disordered tear film. Trans Ophthalmol Soc U K. 1985;104(pt 4):374-380.
37. Lemp MA, Holly FJ, Iwata S, et al. The precorneal tear film. I. Factors in spreading and maintaining a continuous tear film over the corneal surface. Arch Ophthalmol. 1970;83:89-94.
38. Fuchs E. Text-Book of Ophthalmology. Philadelphia, PA: JB Lippincott; 1917.
39. Duke-Elder WS, MacFaul PA. The ocular adnexa, part II. Diseases of the eyelids. In: Duke-Elder WS, MacFaul PA, eds. System of Ophthalmology. Vol XIII. London, United Kingdom: H. Kimpton; 1974:241.
40. Keith CG. Seborrhoeic blepharo-kerato-conjunctivitis. Trans Ophthalmol Soc U K. 1967;87:85-103.
41. McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol. 1977;84:788-793.
42. Korb DR, Henriquez AS. Meibomian gland dysfunction and contact lens intolerance. J Am Optom Assoc. 1980;51:243-251.
43. Jester JV, Nicolaides N, Smith RE.Meibomian gland studies: Histologic and ultrastructural investigations. Invest Ophthalmol Vis Sci. 1981;20:537-547. (Pubitemid 11007358)
44. Gutgesell VJ, Stern GA, Hood CI. Histopathology of meibomian gland dysfunction. Am J Ophthalmol. 1982;94:383-387.
45. Straatsma BR. Cystic degeneration of the meibomian glands. AMA Arch Ophthalmol. 1959;61:918-927.
46. Robin JB, Jester JV, Nobe J, et al. In vivo transillumination biomicroscopy and photography of meibomian gland dysfunction. A clinical study. Ophthalmology. 1985;92:1423-1426.
47. Ong BL, Hodson SA, Wigham T, et al. Evidence for keratin proteins in normal and abnormal human meibomian fluids. Curr Eye Res. 1991;10: 1113-1119.
48. Seal DV, McGill JI, Jacobs P, et al. Microbial and immunological investigations of chronic non-ulcerative blepharitis and meibomianitis. Br J Ophthalmol. 1985;69:604-611.
49. Gilbard JP, Rossi SR, Heyda KG. Tear film and ocular surface changes after closure of the meibomian gland orifices in the rabbit. Ophthalmology. 1989;96:1180-1186.
50. Obata H. Anatomy and histopathology of human meibomian gland. Cornea. 2002;21(Suppl 7):S70-S74.
51. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995;113:1266-1270.
52. Lee SH, Tseng SC. Rose bengal staining and cytologic characteristics associated with lipid tear deficiency. Am J Ophthalmol. 1997;124: 736-750.
53. Goto E, Shimazaki J, Monden Y, et al. Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology. 2002;109:2030-2035.
54. Meibomius H. De Vasis Palpebrarum Novis Epistola Muller. Helmstadt; 1666.
55. Mackenzie W. Practical Treatise on the Diseases of the Eye. 2nd ed. London, United Kingdom: Longman; 1835:149.
56. Elschnig VP. Beitrag zur aetiologie und therapie derchronischen conjunctivitis. Dtsch Med Wodenschr. 1908;34:1133-1135.
57. Cowper HW. Meibomian seborrhea. Am J Ophthalmol. 1922;5:25-30.
58. Filatov WP. Keratitis meibomiana. Klin Monatsbl Augenheilkd. 1930;84: 380-384.
59. Gifford SR. Meibomian glands in chronic blepharoconjunctivitis. Am J Ophthalmol. 1921;4:489-494.
60. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173-1180.
61. Aubaret. Bull Soc Franc Ophthal. 1929;42.
62. Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland dysfunction in chronic blepharitis. Cornea. 1991;10:277-285.
63. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology. 1993;100:347-351.
64. Bron AJ, Tiffany JM. The meibomian glands and tear film lipids. Structure, function, and control. Adv Exp Med Biol. 1998;438:281-295.
65. Craig JP, Blades K, Patel S. Tear lipid layer structure and stability following expression of the meibomian glands. Ophthalmic Physiol Opt. 1995;15:569-574.
66. Norn M. Expressibility of meibomian secretion. Relation to age, lipid precorneal film, scales, foam, hair and pigmentation. Acta Ophthalmol (Copenh). 1987;65:137-142.
67. Hom MM, Silverman MW. Displacement technique and meibomian gland expression. J Am Optom Assoc. 1987;58:223-226.
68. Romero JM, Biser SA, Perry HD, et al. Conservative treatment of meibomian gland dysfunction. Eye Contact Lens. 2004;30:14-19.
69. Korb DR, Greiner, JV. Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction. Adv Exp Biol. 1994;350; 293-298.
70. Foulks GN. Blepharitis: Lid margin disease and the ocular surface. In: Holland EJ, Mannis MJ, eds. Ocular Surface Disease: Medical and Surgical Management. New York, NY: Springer; 2002: Chap 3.
71. Mastrota KM. The MeibomianMastrota paddle [Cynacon/OcusoftWebsite]. Available at: Http://www.ocusoft.com/news-briefs/art-1-11-06.htm. Accessed April 21, 2009.
72. Shimazaki J, Goto E, Ono M, et al. Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology. 1998;105:1485-1488.
73. Sotozono C, Ang LP, Koizumi N, et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens- Johnson syndrome. Ophthalmology. 2007;114:1294-1302.
74. Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: Correlation with dry eye symptoms and gland location. Cornea. 2008;27: 1142-1147.
75. Miller D. Pressure of the lid on the eye. Arch Ophthalmol. 1967;78: 328-330.
76. CombergW, Stoewer E.DieAugendruck-steingendeWirkung vershiedener muskelaktionen und ihre Bedeutun. Z Augenheilk. 1923;58:617.
77. Norn MS. Semiquantitative interference study of fatty layer of precorneal film. Acta Ophthalmol (Copenh). 1979;57:766-774.
78. Doughty MJ, Naase T, Donald C, et al. Visualisation of "Marx's line" along the marginal eyelid conjunctiva of human subjects with lissamine green dye. Ophthalmic Physiol Opt. 2004;24:1-7.
79. Yamaguchi M, Kutsuna M, Uno T, et al. Marx line: Fluorescein staining line on the inner lid as indicator of meibomian gland function. Am J Ophthalmol. 2006;141:669-675.
80. Norn M. Meibomian orifices and Marx's line. Studied by triple vital staining. Acta Ophthalmol (Copenh). 1985;63:698-700.
81. Henriquez AS, Korb DR. Meibomian glands and contact lens wear. Br J Ophthalmol. 1981;65:108-111.
82. Fenga C, Aragona P, Cacciola A, et al. Meibomian gland dysfunction and ocular discomfort in video display terminal workers. Eye. 2008;22: 91-95.
83. Borchman D, Foulks GN, Yappert MC, et al. Factors affecting evaporation rates of tear film components measured in vitro. Eye Contact Lens. 2009;35:32-37.
84. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23: 762-770.
85. Linton RG, Curnow DH, Riley WJ. The meibomian glands. An investigation into the secretion and some aspects of the physiology. Br J Ophthalmol. 196l;45:718-723.
86. Korb DR, Baron DF, Herman JP, et al. Tear film lipid layer thickness as a function of blinking. Cornea. 1994;13:354-359.
87. Goto E, Yagi Y, Matsumoto Y, et al. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol. 2002;133:181-186. (Pubitemid 34072045)
88. Goto E, Yagi Y, Kaido M, et al. Improved functional visual acuity after punctal occlusion in dry eye patients. Am J Ophthalmol. 2003;135: 704-705.
89. Martin NF, Rubinfeld RS, Malley JD, et al. Giant papillary conjunctivitis and meibomian gland dysfunction blepharitis. CLAO J. 1992;18:165.
90. Mathers WD, Lane JA, Zimmerman MB. Assessment of the tear film with tandem scanning confocal microscopy. Cornea. 1997;16:162-168.
91. Goto E, Tseng SC. Kinetic analysis of tear interference images in aqueous tear deficiency dry eye before and after punctal occlusion. Invest Ophthalmol Vis Sci. 2003;44:1897-1905. (Pubitemid 36520278)
92. Korb DR, Greiner JV, Glonek T, et al. Effect of periocular humidity on the tear film lipid layer. Cornea. 1996;15:129-134. (Pubitemid 26061309)
93. Bron AJ, Yokoi N, Gafney E, et al. Predicted phenotypes of dry eye: Proposed consequences of its natural history. Ocul Surf. 2009;7:78-92.
94. Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol. 1984;68:524-528.
95. Dougherty JM, McCulley JP. Analysis of the free fatty acid component of meibomian secretions in chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:52-56.
96. McCulley JP, Shine WE. Changing concepts in the diagnosis and management of blepharitis. Cornea. 2000;19:650-658.
97. Barton K, Monroy DC, Nava A, et al. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology. 1997;104:1868-1874.
98. Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
99. Afonso AA, Monroy D, Stern ME, et al. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology. 1999;106:803-810.
100. Macri A, Pflugfelder S. Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease. Arch Ophthalmol. 2000;118:1632-1638.
101. Duke-Elder WS, MacFaul PA. The ocular adnexa, part II. Diseases of the eyelids. In: Duke-Elder WS, MacFaul PA, eds. System of Ophthalmology. Vol XIII. London, United Kingdom: H. Kimpton; 1974:242.
102. Mori A, Oguchi Y, Goto E, et al. Efficacy and safety of infrared warming of the eyelids. Cornea. 1999;18:188-193.
103. Mori A, Shimazaki J, Shimmura S, et al. Disposable eyelid-warming device for the treatment of meibomian gland dysfunction. Jpn J Ophthalmol. 2003;47:578-586.
104. Matsumoto Y, Dogru M, Goto E, et al. Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea. 2006;25:644-650.
105. Fuller JR.Therapeutic eye and eyelid cover. US Patent application publication. US Patent 2004 0237969 A1. December 2, 2004.
106. Mitra M, Menon GJ, Casini A, et al. Tear film lipid layer thickness and ocular comfort after meibomian therapy via latent heat with a novel device in normal subjects. Eye. 2005;19:657-660.
107. Di Pascuale MA, Liu TS, Trattler W, et al. Lipid tear deficiency in persistent dry eye after laser in situ keratomileusis and treatment results of new eye-warming device. J Cataract Refract Surg. 2005;31: 1741-1749.
108. Blackie CA, Solomon JD, Greiner JV, et al. Inner eyelid surface temperature as a function of warm compress methodology. Optom Vis Sci. 2008;85:675-683.
109. McCulley JP, Shine WE. The lipid layer of tears: Dependent on meibomian gland function. Exp Eye Res. 2004;78:361-365.
110. Shine WE, McCulley JP. The role of cholesterol in chronic blepharitis. Invest Ophthalmol Vis Sci. 1991;32:2272-2280.
111. Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol. 1996;122:818-824.
112. Terada O, Chiba K, Senoo T, et al. Ocular surface temperature of meibomian gland dysfunction patients and the melting point of meibomian gland secretions. Nippon Ganka Gakkai Zasshi. 2004;108:690-693.
113. Despa F, Orgill DP, Neuwalder J, et al. The relative thermal stability of tissue macromolecules and cellular structure in burn injury. Burns. 2005; 31:568-577.
114. Olson MC, Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens. 2003;29:96-99.
115. Nagymihalyi A, Dikstein S, Tiffany JM. The influence of eyelid temperature on the delivery of meibomian oil. Exp Eye Res. 2004;78: 367-370.
116. Solomon JD, Case CL, Greiner JV, et al. Warm compress induced visual degradation and Fischer-Schweitzer polygonal reflex. Optom Vis Sci. 2007;84:580-587.
117. Lemp MA, Bardfield L, Blackie CA, et al. Evaluation of a novel method of treatment of dry eye. Invest Ophthalmol Vis Sci. 2008:127:A154.
118. Paugh JR, Knapp LL, Martinson JR, et al. Meibomian therapy in problematic contact lens wear. Optom Vis Sci. 1990;67:803-806.
119. Dougherty JM, McCulley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:486-491.
120. Dougherty JM, McCulley JP, Silvany RE, et al. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci. 1991;32:2970-2975.
121. Golub LM, Ramamurthy NS, McNamara TF, et al. Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med. 1991;2:297-321.
122. Li DQ, Lokeshwar BL, Solomon A, et al. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res. 2001;73:449-459.
123. Smith VA, Khan-Lim D, Anderson L, et al. Does orally administered doxycycline reach the tear film? Br J Ophthalmol. 2008;92:856-859.
124. Souchier M, Joffre C, Gregoire S, et al. Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment. Br J Ophthalmol. 2008;92:819-822.
125. Yoo SE, Lee DC, Chang MH. The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean J Ophthalmol. 2005;19:258-263.
126. Ianaro A, Ialenti A, Maffia P, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther. 2000;292:156-163.
127. Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther. 2008;25:858-870.
128. Perry HD, Doshi-Carnevale S, Donnenfeld ED, et al. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea. 2006;25:171-175.
129. Rubin M, Rao SN. Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis. J Ocul Pharmacol Ther. 2006;22:47-53.
130. Avunduk AM, Avunduk MC, Varnell ED, et al. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: A clinical and immunocytochemical study. Am J Ophthalmol. 2003;136:593-602.
131. Sainz de la Maza Serra SM, Simon Castellvi C, Kabbani O, et al. Nonpreserved topical steroids and punctal occlusion for severe keratoconjunctivitis sicca. Arch Soc Esp Oftalmol. 2000;75:751-756.
132. Hyon JY, Lee YJ, Yun PY. Management of ocular surface inflammation in Sjogren syndrome. Cornea. 2007;26:S13-S15.
133. Herman JP, Korb DR, Greiner JV, et al. Treatment of lid wiper epitheliopathy with a metastable lipid emulsion or a corticosteroid. Invest Ophthalmol Vis Sci. 2005;46:S 2017.
134. Sullivan BD, Evans JE, Krenzer KL, et al. Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocrinol Metab. 2000;85:4866-4873.
135. Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab. 2000;85:4874-4882.
136. Paranjpe DR, Foulks GN. Therapy for meibomian gland disease. Ophthalmol Clin North Am. 2003;16:37-42.
137. Gilbard JP, Carter JB, Sang DN, et al. Morphologic effect of hyperosmolarity on rabbit corneal epithelium. Ophthalmology. 1984; 91:1205-1212.
138. Gilbard JP, Farris RL. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. Arch Ophthalmol. 1979;97:1642-1646.
139. Korb DR, Greiner JV, Glonek T. The effects of anionic and zwitterionic phospholipids on the tear film lipid layer. Adv Exp Med Biol. 2002;506(pt A):495-499. (Pubitemid 36307711)
140. Scaffidi RC, Korb DR. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness. Eye Contact Lens. 2007;33:38-44.
141. Di Pascuale MA, Goto E, Tseng SC. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients. Ophthalmology. 2004;111:783-791.
142. Solomon R, Perry HD, Donnenfeld ED, et al. Slitlamp biomicroscopy of the tear film of patients using topical Restasis and Refresh Endura. J Cataract Refract Surg. 2005;31:661-663.
143. Novagali Pharma. Cationorm emulsion drop. Available at: Http://www.novagali.com. Assessed on April 30, 2009.
144. Maskin SL. Intraductal meibomian gland probing relieves symptoms of obstructive MGD. Invest Ophthalmol Vis Sci. 2009:4636/D880.
145. Goto E, Dogru M, Fukagawa K, et al. Successful tear lipid layer treatment for refractory dry eye in office workers by low-dose lipid application on the full-length eyelid margin. Am J Ophthalmol. 2006; 142:264-270.